OpenCapitalBeta

Calendar Stocks Metrics

/

Stocks
Insmed
Business Segments
Products & Services
Product revenues, net

Product revenues, net

Insmed·Products & Services·2 segments·Rolls up to Total Revenue

Breakdown

Segments

ARIKAYCE external R&D expensesView metric

BRINSUPRIView metric

Navigation

Earnings Calendar
Stocks
Pricing
About
Methodology

Connect

Claude (MCP)
ChatGPT (MCP)
Portfolio (Plaid)

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

OpenCapital

Segment	Q3 '25	Q1 '26
BRINSUPRI	$28.05M	$207.85M
ARIKAYCE external R&D expenses	$114.29M	$98.11M
Total	$142.34M	$305.96M